Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
Clinical trial NCT00369434 · COMPLETED
Trial details
- NCT number
- NCT00369434
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.